ArticleTranslational cancer research2025
Molecular subtype and prognostic model of laryngeal squamous cell carcinoma based on neutrophil extracellular trap-related genes.
Article in Translational cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- An LSCC-specific R-loop-related model predicts prognosis and neoadjuvant immunotherapy response and identifies EIF5A2-mediated tumor-immune crosstalk.World journal of surgical oncology · 2026Article
- Single-Cell Transcriptomics Identifies Novel Prognostic Signatures in HNSCC Immunotherapy Response.Cancer science · 2025Article
- The functional and clinical significance of nucleoporin NUP153 across human cancers: a systematic study based on multi-omics analysis and bench work validation.Frontiers in immunology · 2025Article
- Perineural invasion as a neuro-immune niche in head and neck cancer: mechanisms of immune evasion and therapeutic implications.Frontiers in immunology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Laryngeal squamous cell carcinoma (LSCC) is a prevalent type of head and neck cancer with a poor prognosis due to late diagnosis and limited biomarkers. Neutrophil extracellular traps (NETs) play a critical role in cancer biology, but their involvement in LSCC is not well understood. This study aimed to explore NET's role in LSCC. Methods: Differentially expressed NET-related genes (DE-NRGs) were identified using GSE10935 datasets and data from The Cancer Genome Atlas (TCGA) database. Functional enrichment and pathway analyses were conducted to elucidate their roles. Consensus clustering identified LSCC molecular subtypes. Immune landscape analyses revealed the tumor microenvironment of different subtypes. A prognostic model was developed using least absolute shrinkage and selection operator(LASSO) regression and validated in external datasets. Results: We identified 27 DE-NRGs in LSCC, and these genes were involved in heparin binding, cytokine activity, and leukocyte migration. Three molecular subtypes (C1, C2, and C3) were identified, with C3 showing the worst prognosis. Immune landscape analysis revealed significant differences in immune cell infiltration among subtypes. Higher expression of immune checkpoint genes in C2 suggested better immunotherapy outcomes. The prognostic model, based on seven hub DE-NRGs ( Conclusions: The study identified DE-NRGs as potential biomarkers and developed a robust prognostic model for LSCC. These findings offer insights into LSCC's molecular basis and highlight NETs' role in prognosis and immune landscape.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.